Image 1
Metronidazole Tablet
Product Images NDC 50111-334
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metronidazole (NDC 50111-334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Metronidazole Tablets USP, 250 mg, indicated for the treatment of bacterial infections, contain 250 mg of metronidazole, USP in each tablet. Patients must refer to the package insert for the recommended dosage instruction. The product must be stored within the temperature range of 20° to 25°C (68° to 77°F) and protected from light. The metronidazole must be packaged in a light-resistant container and kept away from children. The medicine is manufactured in Gzech Republic, by TEVA CZECH INDUSTRIES, Opava-Komarov, and distributed in the US by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.*
Image 4
Metronidazole USP Tablets of strength 500mg, NDC 50111-334-01, are to be stored at 20°C - 25°C and protected from light. The medicine is manufactured by Teva Czech Industries in the Czech Republic and is to be dispensed in a tight, light-resistant container with a child-resistant closure. The usual dosage should be as directed by the prescribing physician and additional information can be found in the package insert. This medication should be kept away from children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
